L'Oreal Overtakes LVMH on Paris Bourse
Analysis based on 9 articles · First reported Sep 15, 2026 · Last updated Sep 15, 2026
The milestone highlights a rotation within French equities away from luxury toward consumer staples like cosmetics, as LVMH's declining market value reflects structural demand weakness in high-end goods. Broader market sentiment for the luxury sector remains negative, while L Oréal benefits from the lipstick effect and defensive positioning amid economic uncertainty in China and European Union — Europe.
On September 15, 2026, L Oréal became France's most valuable listed company, surpassing LVMH in market capitalisation at the close of trading on the Paris bourse. L Oréal's market capitalisation reached approximately 203.17 billion euros (234.54 billion US dollars), while LVMH stood at about 202.05 billion euros, according to LSEG data. It is the first time since 2017 that a non-luxury company has claimed the top spot on the Paris exchange at the end of a trading day. The shift reflects prolonged pressure on high-end luxury companies, which have faced years of slowing sales and lacklustre earnings. Berenberg analyst Nick Anderson attributed the trend to the lipstick effect, noting that consumers facing a bleak economic mood prefer small indulgences over expensive luxury items. The global luxury industry has contracted over the last three years, hit by an economic slump in China and the war in the Middle East, with consultancy Bain estimating that around 60 million consumers have turned away from luxury goods. L Oréal shares are up 5 percent this year, while LVMH shares have fallen 35 percent year-to-date and were down 2.3 percent on Tuesday. LVMH also lost its place among European Union — Europe's ten largest companies by market capitalisation, and its CEO Bernard Arnault reportedly lost his title as European Union — Europe's wealthiest person to Zara founder Amancio Ortega, according to Forbes' real-time billionaire ranking. LVMH is now dwarfed by chipmaker ASML, worth three times as much, and Swiss pharmaceutical giants Roche and Novartis. DWS equity portfolio manager Stefan Bauknecht said L Oréal's new lead could well be here to stay.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard